Early access
Sign in
Taking peopleNo phase

Using computer analysis of lung scans to predict worsening in sudden pulmonary embolism

Builds an artificial intelligence tool using CT scans to predict worse outcomes in pulmonary embolism.

Key facts

Who runs it
Shengjing Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Status
Recruiting
People taking part
2,000 people, planned
Started
1 Jan 2011
Expected to end
31 Dec 2026
Type of study
Observational
Record updated
11 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with acute pulmonary embolism (a blood clot in the lungs) found on a CT scan of the lung arteries. It uses existing data to build an artificial intelligence tool that predicts bad outcomes.

Age
18 years and older
Sex
All sexes
Disease stage
Pulmonary embolism diagnosed by CT pulmonary angiography (a CT scan of the lung blood vessels)
Earlier treatment
People cannot join if they had reperfusion treatment (treatment to reopen the blocked vessel) before admission to hospital.

Main reasons for not taking part

  • Pregnancy
  • Reperfusion treatment before admission
  • Missing data on CT parameters, echocardiography (heart ultrasound), cardiac troponin I (c-Tn I) or NT-pro BNP levels

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography

Who cannot take part

  • missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels
  • pregnancy
  • reception of reperfusion treatment before admission

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prediction of Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Plain-language title
Using computer analysis of lung scans to predict worsening in sudden pulmonary embolismGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
11 March 2026